Dr Meredith Irwin

Dr Meredith Irwin is a Professor of Paediatrics and Clinician-scientist focused on translational neuroblastoma research at the Hospital for Sick Children (Sick Kids) and University of Toronto.

She completed her medical training in paediatrics and oncology at Boston Children’s Hospital and Dana-Farber Cancer Institute at Harvard Medical School. Dr. Irwin joined the Division of Haematology/Oncology at SickKids in April 2002 and has led the Sick Kids Neuroblastoma Program since its inception in 2007.

In 2020 she was appointed as Paediatrician-in-Chief and Chair of Paediatrics at the University of Toronto. She is also a Senior Scientist in Cell Biology at the Sick Kids Research Institute where her laboratory studies the genes and pathways that regulate cell growth and metastasis in neuroblastoma to identify novel therapeutic targets .

Dr. Irwin leads neuroblastoma clinical trials, risk classification and biomarker development as Chair of Neuroblastoma Biology for the Children’s Oncology Group (COG). She is also a member of the executive committees for the International Neuroblastoma Research Group (INRG) and the Canadian precision oncology PROFYLE program.